Showing results (141-150 of 541) with videos related to
Sort By:
Pageof 55
Hepatology (Baltimore, Md.)|August 2, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.Iscience|August 14, 2023
Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosisYasmina Chouik, Fanny Lebossé, Marie-Laure Plissonnier, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2023
Axon guidance molecules in liver pathology: Journeys on a damaged passportIevgeniia Chicherova, Charlotte Hernandez, Fanny Mann, et al.The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.Cancers|July 2, 2021
The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and BeyondVincenzo Alfano, Mirjam B Zeisel, Massimo Levrero, et al.Gastroenterology|October 13, 2006
Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patientStéphanie Villet, Christian Pichoud, Jean-Pierre Villeneuve, et al.Hepatology (Baltimore, Md.)|November 13, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints ConferenceMarkus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2018
Very late relapse of hepatitis C virus infection immediately after liver transplantDomitille Erard-Poinsot, Caroline Scholtès, Claire Billoud, et al.Journal of Hepatology|November 16, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference<sup>‡</sup>Markus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.Viruses|November 2, 2018
Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular CarcinomaMarie-Laure Plissonnier, Katharina Herzog, Massimo Levrero, et al.Pageof 55